YAP1 and cancer: In line with the YAP/TAZ target genes, upregulation of YAP/TAZ was associated with poor prognosis and/or poor clinical outcome in numerous cancers including lung, breast, colorectal, pancreatic, gastric, esophageal, bladder, skin, and gender specific tumors in the prostate, endometrium, and ovaria (Cordenonsi et al. 2011; Noguchi et al. 2014; Saadeldin et al. 2014; Moroishi et al. 2015; Bonilla et al. 2016; Lo Sardo et al. 2018; Sheng et al. 2019).